Stockreport

Neuron23 Announces Usage of Roche's Digital Biomarker and Device in Parkinson's Disease Clinical Trial [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF SOUTH SAN FRANCISCO, Calif., November 19, 2024 BUSINESS WIRE )--Neuron23® Inc., a clinical-stage biotechnology company focused on developing precision medicines for gen [Read more]